Which has better earnings and valuation, DOCS or COA?

Coats Group has higher revenue and earnings than Dr. Martens. Coats Group is trading at a lower price-to-earnings ratio than Dr. Martens, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Dr. Martens £764.90M 1.02 £68.97M £2.40 34.08 Coats Group £1.60B 0.96 £75.12M £5.39 14.84

Is DOCS or COA more profitable?

Coats Group has a net margin of 6.60% compared to Dr. Martens' net margin of 3.11%. Coats Group's return on equity of 14.43% beat Dr. Martens' return on equity. Company Net Margins Return on Equity Return on Assets Dr. Martens 3.11% 6.89% 8.12% Coats Group 6.60% 14.43% 8.48%

Do analysts recommend DOCS or MUL?

Dr. Martens presently has a consensus target price of GBX 105, suggesting a potential upside of 28.36%. Given Dr. Martens' stronger consensus rating and higher possible upside, analysts clearly believe Dr. Martens is more favorable than Mulberry Group. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Dr. Martens 0 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.67 Mulberry Group 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Which has stronger earnings and valuation, DOCS or MUL?

Dr. Martens has higher revenue and earnings than Mulberry Group. Mulberry Group is trading at a lower price-to-earnings ratio than Dr. Martens, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Dr. Martens £764.90M 1.02 £68.97M £2.40 34.08 Mulberry Group £125.47M 1.27 -£39.32M £13.00 17.45

Do analysts rate DOCS or PTD?

Dr. Martens presently has a consensus price target of GBX 105, indicating a potential upside of 28.36%. Given Dr. Martens' stronger consensus rating and higher possible upside, research analysts plainly believe Dr. Martens is more favorable than Pittards. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Dr. Martens 0 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.67 Pittards 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Which has preferable earnings and valuation, DOCS or PTD?

Dr. Martens has higher revenue and earnings than Pittards. Pittards is trading at a lower price-to-earnings ratio than Dr. Martens, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Dr. Martens £764.90M 1.02 £68.97M £2.40 34.08 Pittards £20.37M 0.00 N/A £0.03 N/A

Is DOCS or PTD more profitable?

Dr. Martens has a net margin of 3.11% compared to Pittards' net margin of 1.97%. Dr. Martens' return on equity of 6.89% beat Pittards' return on equity. Company Net Margins Return on Equity Return on Assets Dr. Martens 3.11% 6.89% 8.12% Pittards 1.97% 3.08% 2.32%

Do analysts recommend NBU or DOCS?

Dr. Martens has a consensus price target of GBX 105, suggesting a potential upside of 28.36%. Given Dr. Martens' stronger consensus rating and higher possible upside, analysts clearly believe Dr. Martens is more favorable than Naibu Global International. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Naibu Global International 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Dr. Martens 0 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.67

Which has higher earnings and valuation, NBU or DOCS?

Dr. Martens has higher revenue and earnings than Naibu Global International. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Naibu Global International N/A N/A N/A N/A N/A Dr. Martens £764.90M 1.02 £68.97M £2.40 34.08

Dr. Martens (DOCS) Competitors

GBX 81.80 +2.90 (+3.68%)

As of 08/21/2026 12:44 PM Eastern

Compare

DOCS vs. WOSG, COA, MUL, PTD, and NBU

Should you buy Dr. Martens stock or one of its competitors? Dr. Martens's main competitors and comparable companies include Watches of Switzerland Group (WOSG), Coats Group (COA), Mulberry Group (MUL), Pittards (PTD), and Naibu Global International (NBU). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "textiles, apparel & luxury goods" industry.

How does Dr. Martens compare to Watches of Switzerland Group?

Dr. Martens (LON:DOCS) and Watches of Switzerland Group (LON:WOSG) are both small-cap consumer discretionary companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, valuation, analyst recommendations, media sentiment, earnings, profitability, risk and dividends.

Dr. Martens has a beta of 0.261, indicating that its share price is 74% less volatile than the broader market. Comparatively, Watches of Switzerland Group has a beta of 1.867, indicating that its share price is 87% more volatile than the broader market.

Watches of Switzerland Group has a net margin of 5.42% compared to Dr. Martens' net margin of 3.11%. Watches of Switzerland Group's return on equity of 16.31% beat Dr. Martens' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Dr. Martens	3.11%	6.89%	8.12%
Watches of Switzerland Group	5.42%	16.31%	7.41%

In the previous week, Watches of Switzerland Group had 1 more articles in the media than Dr. Martens. MarketBeat recorded 1 mentions for Watches of Switzerland Group and 0 mentions for Dr. Martens. Dr. Martens' average media sentiment score of 0.00 equaled Watches of Switzerland Group'saverage media sentiment score.

Company	Overall Sentiment
Dr. Martens	Neutral
Watches of Switzerland Group	Neutral

Dr. Martens has higher earnings, but lower revenue than Watches of Switzerland Group. Watches of Switzerland Group is trading at a lower price-to-earnings ratio than Dr. Martens, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Dr. Martens	£764.90M	1.02	£68.97M	£2.40	34.08
Watches of Switzerland Group	£1.83B	0.86	£60.02M	£42.60	15.96

41.9% of Dr. Martens shares are owned by institutional investors. Comparatively, 54.1% of Watches of Switzerland Group shares are owned by institutional investors. 2.9% of Dr. Martens shares are owned by insiders. Comparatively, 4.5% of Watches of Switzerland Group shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Dr. Martens currently has a consensus price target of GBX 105, indicating a potential upside of 28.36%. Watches of Switzerland Group has a consensus price target of GBX 596.67, indicating a potential downside of 12.25%. Given Dr. Martens' higher probable upside, research analysts plainly believe Dr. Martens is more favorable than Watches of Switzerland Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Dr. Martens	0 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.67
Watches of Switzerland Group	0 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.67

Summary

Watches of Switzerland Group beats Dr. Martens on 8 of the 13 factors compared between the two stocks.

How does Dr. Martens compare to Coats Group?

Dr. Martens (LON:DOCS) and Coats Group (LON:COA) are both small-cap consumer discretionary companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, risk, earnings, analyst recommendations, valuation, media sentiment, institutional ownership and profitability.

Dr. Martens pays an annual dividend of GBX 2.55 per share and has a dividend yield of 3.1%. Coats Group pays an annual dividend of GBX 3.28 per share and has a dividend yield of 4.1%. Dr. Martens pays out 106.3% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Coats Group pays out 60.9% of its earnings in the form of a dividend. Coats Group is clearly the better dividend stock, given its higher yield and lower payout ratio.

Dr. Martens presently has a consensus price target of GBX 105, suggesting a potential upside of 28.36%. Coats Group has a consensus price target of GBX 121.20, suggesting a potential upside of 51.50%. Given Coats Group's stronger consensus rating and higher probable upside, analysts clearly believe Coats Group is more favorable than Dr. Martens.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Dr. Martens	0 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.67
Coats Group	0 Sell rating(s)	0 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	3.00

41.9% of Dr. Martens shares are owned by institutional investors. Comparatively, 63.8% of Coats Group shares are owned by institutional investors. 2.9% of Dr. Martens shares are owned by company insiders. Comparatively, 3.2% of Coats Group shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Coats Group has a net margin of 6.60% compared to Dr. Martens' net margin of 3.11%. Coats Group's return on equity of 14.43% beat Dr. Martens' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Dr. Martens	3.11%	6.89%	8.12%
Coats Group	6.60%	14.43%	8.48%

Dr. Martens has a beta of 0.261, indicating that its share price is 74% less volatile than the broader market. Comparatively, Coats Group has a beta of 1.259, indicating that its share price is 26% more volatile than the broader market.

In the previous week, Coats Group had 1 more articles in the media than Dr. Martens. MarketBeat recorded 1 mentions for Coats Group and 0 mentions for Dr. Martens. Dr. Martens' average media sentiment score of 0.00 equaled Coats Group'saverage media sentiment score.

Company	Overall Sentiment
Dr. Martens	Neutral
Coats Group	Neutral

Coats Group has higher revenue and earnings than Dr. Martens. Coats Group is trading at a lower price-to-earnings ratio than Dr. Martens, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Dr. Martens	£764.90M	1.02	£68.97M	£2.40	34.08
Coats Group	£1.60B	0.96	£75.12M	£5.39	14.84

Summary

Coats Group beats Dr. Martens on 15 of the 17 factors compared between the two stocks.

How does Dr. Martens compare to Mulberry Group?

Dr. Martens (LON:DOCS) and Mulberry Group (LON:MUL) are both small-cap consumer discretionary companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, dividends, earnings, analyst recommendations, profitability, media sentiment, institutional ownership and risk.

Dr. Martens presently has a consensus target price of GBX 105, suggesting a potential upside of 28.36%. Given Dr. Martens' stronger consensus rating and higher possible upside, analysts clearly believe Dr. Martens is more favorable than Mulberry Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Dr. Martens	0 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.67
Mulberry Group	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

41.9% of Dr. Martens shares are held by institutional investors. Comparatively, 0.5% of Mulberry Group shares are held by institutional investors. 2.9% of Dr. Martens shares are held by company insiders. Comparatively, 1.4% of Mulberry Group shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Dr. Martens has a beta of 0.261, indicating that its stock price is 74% less volatile than the broader market. Comparatively, Mulberry Group has a beta of 0.628, indicating that its stock price is 37% less volatile than the broader market.

Dr. Martens has a net margin of 3.11% compared to Mulberry Group's net margin of -6.72%. Mulberry Group's return on equity of 78.71% beat Dr. Martens' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Dr. Martens	3.11%	6.89%	8.12%
Mulberry Group	-6.72%	78.71%	-8.70%

In the previous week, Dr. Martens' average media sentiment score of 0.00 equaled Mulberry Group'saverage media sentiment score.

Company	Overall Sentiment
Dr. Martens	Neutral
Mulberry Group	Neutral

Dr. Martens has higher revenue and earnings than Mulberry Group. Mulberry Group is trading at a lower price-to-earnings ratio than Dr. Martens, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Dr. Martens	£764.90M	1.02	£68.97M	£2.40	34.08
Mulberry Group	£125.47M	1.27	-£39.32M	£13.00	17.45

Summary

Dr. Martens beats Mulberry Group on 10 of the 14 factors compared between the two stocks.

How does Dr. Martens compare to Pittards?

Dr. Martens (LON:DOCS) and Pittards (LON:PTD) are both small-cap consumer discretionary companies, but which is the superior business? We will compare the two businesses based on the strength of their analyst recommendations, valuation, institutional ownership, media sentiment, risk, profitability, dividends and earnings.

Dr. Martens has a beta of 0.261, indicating that its stock price is 74% less volatile than the broader market. Comparatively, Pittards has a beta of 0.67, indicating that its stock price is 33% less volatile than the broader market.

Dr. Martens pays an annual dividend of GBX 2.55 per share and has a dividend yield of 3.1%. Pittards pays an annual dividend of GBX 1 per share. Dr. Martens pays out 106.3% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Pittards pays out 3,333.3% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Dr. Martens is clearly the better dividend stock, given its higher yield and lower payout ratio.

In the previous week, Dr. Martens' average media sentiment score of 0.00 equaled Pittards'average media sentiment score.

Company	Overall Sentiment
Dr. Martens	Neutral
Pittards	Neutral

Dr. Martens has higher revenue and earnings than Pittards. Pittards is trading at a lower price-to-earnings ratio than Dr. Martens, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Dr. Martens	£764.90M	1.02	£68.97M	£2.40	34.08
Pittards	£20.37M	0.00	N/A	£0.03	N/A

Dr. Martens has a net margin of 3.11% compared to Pittards' net margin of 1.97%. Dr. Martens' return on equity of 6.89% beat Pittards' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Dr. Martens	3.11%	6.89%	8.12%
Pittards	1.97%	3.08%	2.32%

Dr. Martens presently has a consensus price target of GBX 105, indicating a potential upside of 28.36%. Given Dr. Martens' stronger consensus rating and higher possible upside, research analysts plainly believe Dr. Martens is more favorable than Pittards.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Dr. Martens	0 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.67
Pittards	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

41.9% of Dr. Martens shares are owned by institutional investors. Comparatively, 30.0% of Pittards shares are owned by institutional investors. 2.9% of Dr. Martens shares are owned by insiders. Comparatively, 68.6% of Pittards shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Summary

Dr. Martens beats Pittards on 11 of the 14 factors compared between the two stocks.

How does Dr. Martens compare to Naibu Global International?

Naibu Global International (LON:NBU) and Dr. Martens (LON:DOCS) are both consumer discretionary companies, but which is the superior business? We will contrast the two companies based on the strength of their media sentiment, valuation, analyst recommendations, profitability, risk, earnings, dividends and institutional ownership.

Dr. Martens has higher revenue and earnings than Naibu Global International.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Naibu Global International	N/A	N/A	N/A	N/A	N/A
Dr. Martens	£764.90M	1.02	£68.97M	£2.40	34.08

41.9% of Dr. Martens shares are owned by institutional investors. 2.9% of Dr. Martens shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

In the previous week, Naibu Global International's average media sentiment score of 0.00 equaled Dr. Martens'average media sentiment score.

Company	Overall Sentiment
Naibu Global International	Neutral
Dr. Martens	Neutral

Dr. Martens has a net margin of 3.11% compared to Naibu Global International's net margin of 0.00%. Dr. Martens' return on equity of 6.89% beat Naibu Global International's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Naibu Global International	N/A	N/A	N/A
Dr. Martens	3.11%	6.89%	8.12%

Dr. Martens has a consensus price target of GBX 105, suggesting a potential upside of 28.36%. Given Dr. Martens' stronger consensus rating and higher possible upside, analysts clearly believe Dr. Martens is more favorable than Naibu Global International.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Naibu Global International	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Dr. Martens	0 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.67

Summary

Dr. Martens beats Naibu Global International on 9 of the 9 factors compared between the two stocks.

Get Dr. Martens News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

DOCS vs. The Competition

Export

Metric	Dr. Martens	Textiles, Apparel & Luxury Goods Industry	Consumer Discretionary Sector	LON Exchange
Market Cap	£782.93M	£11.37B	£13.21B	£2.54B
Dividend Yield	3.12%	2.74%	56.57%	6.17%
P/E Ratio	34.08	24.30	46.96	367.57
Price / Sales	1.02	9.57	88.66	83,481.74
Price / Cash	14.29	188.36	29.13	27.89
Price / Book	2.16	3.68	3.93	7.19
Net Income	£68.97M	£466.81M	£445.72M	£5.89B
7 Day Performance	-7.12%	-1.07%	-0.26%	0.30%
1 Month Performance	10.69%	0.49%	2.74%	3.31%
1 Year Performance	-10.26%	14.09%	-1.57%	22.13%

Dr. Martens Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
DOCS Dr. Martens	3.4267 of 5 stars	GBX 81.80 +3.7%	GBX 105 +28.4%	-10.3%	£782.93M	£764.90M	34.08	890	Gap Up High Trading Volume
WOSG Watches of Switzerland Group	0.5947 of 5 stars	GBX 737 -2.3%	GBX 596.67 -19.0%	+103.2%	£1.71B	£1.83B	17.30	2,553
COA Coats Group	3.7339 of 5 stars	GBX 84 -0.8%	GBX 121.20 +44.3%	+2.8%	£1.61B	£1.60B	15.58	15,539	News Coverage
MUL Mulberry Group	N/A	GBX 200 +5.3%	N/A	+144.0%	£140.32M	£125.47M	15.38	1,300	Gap Down High Trading Volume
PTD Pittards	N/A	N/A	N/A	N/A	£772K	£20.37M	179.17	1,095

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (LON:DOCS) was last updated on 8/23/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Dr. Martens (DOCS) Competitors

DOCS vs. WOSG, COA, MUL, PTD, and NBU

How does Dr. Martens compare to Watches of Switzerland Group?

Summary

How does Dr. Martens compare to Coats Group?

Summary

How does Dr. Martens compare to Mulberry Group?

Summary

How does Dr. Martens compare to Pittards?

Summary

How does Dr. Martens compare to Naibu Global International?

Summary

Media Sentiment Over Time

DOCS vs. The Competition

Dr. Martens Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Dr. Martens (DOCS) Competitors

DOCS vs. WOSG, COA, MUL, PTD, and NBU

How does Dr. Martens compare to Watches of Switzerland Group?

Which has more risk & volatility, DOCS or WOSG?

Is DOCS or WOSG more profitable?

Does the media favor DOCS or WOSG?

Which has stronger earnings & valuation, DOCS or WOSG?

Do institutionals and insiders have more ownership in DOCS or WOSG?

Do analysts recommend DOCS or WOSG?

Summary

How does Dr. Martens compare to Coats Group?

Is DOCS or COA a better dividend stock?

Do analysts rate DOCS or COA?

Do institutionals and insiders hold more shares of DOCS or COA?

Is DOCS or COA more profitable?

Which has more volatility and risk, DOCS or COA?

Does the media refer more to DOCS or COA?

Which has better earnings and valuation, DOCS or COA?

Summary

How does Dr. Martens compare to Mulberry Group?

Do analysts recommend DOCS or MUL?

Do insiders & institutionals hold more shares of DOCS or MUL?

Which has more volatility and risk, DOCS or MUL?

Is DOCS or MUL more profitable?

Does the media prefer DOCS or MUL?

Which has stronger earnings and valuation, DOCS or MUL?

Summary

How does Dr. Martens compare to Pittards?

Which has more volatility and risk, DOCS or PTD?

Is DOCS or PTD a better dividend stock?

Does the media prefer DOCS or PTD?

Which has preferable earnings and valuation, DOCS or PTD?

Is DOCS or PTD more profitable?

Do analysts rate DOCS or PTD?

Do institutionals and insiders believe in DOCS or PTD?

Summary

How does Dr. Martens compare to Naibu Global International?

Which has higher earnings and valuation, NBU or DOCS?

Do insiders and institutionals hold more shares of NBU or DOCS?

Does the media favor NBU or DOCS?

Is NBU or DOCS more profitable?

Do analysts recommend NBU or DOCS?

Summary

Media Sentiment Over Time

DOCS vs. The Competition

Dr. Martens Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools